Newamsterdam Pharma Co N.V. (NAMS): 10% owner sold ~$1.71M
ForGrowth NAP B.V., 10% owner at Newamsterdam Pharma Co N.V., sold ~$1.71M of Newamsterdam Pharma Co N.V. shares.
- ~$1.71M
- Approx. value · 67K sh @ $25.60
- 11.1M
- Holds after · shares reported
- Traded
- Dec 17, 2024
- Filed
- Dec 18, 2024
What stands out in this filing
- After this sale the filing reports 11,056,966 shares, held indirectly.
- 66,648 shares at an average of $25.60 each, as reported on the form.
- Footnote references a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 13, 2024Insider10% owner sold ~$27K of NAMS shares in the open market
- Nov 14, 2024Insider10% owner sold ~$246K of NAMS shares in the open market
- Nov 15, 2024Insider10% owner sold ~$213K of NAMS shares in the open market
- Nov 18, 2024Insider10% owner sold ~$834K of NAMS shares in the open market
- Dec 10, 2024Insider · 1 personInsiders: 2 sales (~$7.8M)
- Dec 11, 2024Insider · 1 personInsiders: 3 sales (~$3.9M)
- Dec 12, 2024Insider · 1 personInsiders: 2 sales (~$4.2M)
- Dec 13, 2024Insider10% owner sold ~$644K of NAMS shares in the open market
- Dec 16, 2024Insider10% owner sold ~$27K of NAMS shares in the open market
- Dec 17, 2024 · this disclosureInsider10% owner sold ~$1.71M of NAMS shares in the open market
What came next
- Dec 17, 2024Insider10% owner sold ~$1.26M of NAMS shares in the open market
- Dec 18, 2024Insider · 1 personInsiders: 2 sales (~$2.6M)
- Dec 19, 2024Insider10% owner sold ~$1.44M of NAMS shares in the open market
- Dec 20, 2024Insider · 1 personInsiders: 2 sales (~$1.3M)
- Dec 23, 2024Insider10% owner sold ~$641K of NAMS shares in the open market
- Dec 24, 2024Insider10% owner sold ~$415K of NAMS shares in the open market
- Dec 26, 2024Insider10% owner sold ~$870K of NAMS shares in the open market
- Dec 27, 2024Insider10% owner sold ~$1.08M of NAMS shares in the open market
- Dec 30, 2024Insider10% owner sold ~$762K of NAMS shares in the open market
- Mar 4, 2025Insider · 2 peopleInsiders: 1 purchase (~$84K), 1 sale (~$3.1M)
- Mar 26, 2025InsiderDirector purchased ~$26K of NAMS shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Newamsterdam Pharma Co N.V.
For Newamsterdam Pharma Co N.V., OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NAMS page.
Other recent filings by ForGrowth NAP B.V., 10% owner
- SEC Form 4 at Newamsterdam Pharma Co N.V. (NAMS)Jan 2, 2025
- SEC Form 4 at Newamsterdam Pharma Co N.V. (NAMS)Dec 30, 2024
- SEC Form 4 at Newamsterdam Pharma Co N.V. (NAMS)Dec 30, 2024
- SEC Form 4 at Newamsterdam Pharma Co N.V. (NAMS)Dec 26, 2024
- SEC Form 4 at Newamsterdam Pharma Co N.V. (NAMS)Dec 26, 2024
The full history of ForGrowth NAP B.V., 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which Newamsterdam Pharma Co N.V. (NAMS) insider traded, and how much?
ForGrowth NAP B.V., 10% owner at Newamsterdam Pharma Co N.V., sold ~$1.71M of Newamsterdam Pharma Co N.V. shares. 67K shares at $25.60.
When did it happen, and when was it made public?
Traded: Dec 17, 2024. Filed: Dec 18, 2024. That is 1 day between the two dates.
What stands out in this filing?
After this sale the filing reports 11,056,966 shares, held indirectly. 66,648 shares at an average of $25.60 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Newamsterdam Pharma Co N.V. recently?
For Newamsterdam Pharma Co N.V., OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the NAMS page.
Does this mean NAMS stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Newamsterdam Pharma Co N.V.
- SEC Schedule 13GNov 16, 2026
- SEC Form 4Oct 2, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its NAMS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
